Hetero Labs launches generic version of Lapatinib
Hetero Labs has launched a generic version of Lapatinib (250 mg) tablets in India. The product is marketed and distributed under the brand name ‘HERTAB’ […]
New Launches
DRL launches Chlorthalidone tablets in US Markets
Dr Reddy’s Laboratories has launched Chlorthalidone tablets which is used to treat high blood pressure, in the US market. The drug will be made available […]
Piramal launches Xcelerate Integrated Solutions
Piramal Pharma Solutions (PPS), has launched its Xcelerate Integrated Solutions platform which will help a range of verticals – drug discovery, drug substance, drug product, […]
Alchem Life launches PhytoRelief CC a natural supplement for cold and cough
AlchemLife – a brand of Alchem International has launched PhytoRelief-CC is a natural cold, cough and flu supplement containing a unique blend of concentrated plant […]
Lupin launches Potassium Chloride Oral Solution in US Markets
Lupin has launched Potassium Chloride Oral Solution USP, 20 mEq/15mL (10 per cent) and 40 mEq/15 mL (20 per cent) in the US markets. The […]
Sun Pharma launches Kapspargo Sprinkle in US markets
Sun Pharma has launched Kapspargo Sprinkle (metoprolol succinate) extended-release capsules in the US markets. The drug is used for the treatment of hypertension (to lower […]
Natco Pharma launches Posanat – antifungal injection
Natco Pharma has launched generic version of Posaconazole Injection, 300 mg/16.7ml, under its brand POSANAT. It may be noted, the drug is available for the […]
Granules Pharma launches Methylergonovine Maleate Tablets in US market
Granules Pharmaceuticals, a subsidiary of Granules India , has launched the generic version of Methylergonovine Maleate Tablets in US markets. The company will market the […]
Glenmark launches Nourkin Woman – hair growth medication in India
Glenmark Pharmaceuticals has launched Nourkrin Woman, a clinically-proven proteoglycan replacement formula, for normalising hair growth cycle. The product will be exclusively marketed in India by […]
Glenmark Pharma launches Adalimumab in India
Glenmark Pharmaceuticals has launched the biosimilar drug Adalimumab in India. The drug will be marketed under a licensing agreement with Cadila Healthcare Ltd. It is […]